APAC / ASEAN
-
Assessing Clinical and Operational Outcomes of PET-CT in India
- May 21, 2020
- Posted by: Team EMeRG
- Category: APAC / ASEAN, BY BUSINESS CHALLENGES, Nuclear Medicine Equipment, Outcomes Research
No CommentsOur Client: A global medical technologies manufacturer dealing with nuclear medicine equipment Challenge Statement: Our client wanted to develop deep, quantifiable evidence supporting their clinical, operational and financial claims with regards to a newly developed PET-CT Scanner EMeRG Approach: Key hospitals in Tier II/III towns within India having the relevant PET-CT scanner were identified and screened Site visits were -
Mapping of Oncology Infrastructure and Need-gap analysis across ASEAN and APAC
- January 31, 2020
- Posted by: Team EMeRG
- Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, GTM Strategy, ICU equipment, Market Entry Assessment, Maternal & Infant Care, Operating Room devices, Patient Monitoring, Pricing Research
Our Client: A global medical technologies manufacturer dealing with medical devices, medical consumables and drug delivery systems Challenge Statement: For strategic planning regarding pricing, market access and overall marketing strategy, the client wanted to understand the future outlook of reimbursement of medical consumables in India EMeRG Approach: Desk Research - An exhaustive desk research was conducted across medical literature and commercial open sources to map the impact of diabetes on Indian population. Desk research was also conducted to understand the current market dynamics of medical consumables and pathology labs in India In Depth Interviews were conducted with diabetologists and other specialists, Medical Directors of hospitals; pathology lab owners; BU Heads and product managers at Health insurance companies; pharmacists and patients Research Outcome: Reimbursement as a terminology was loosely understood in India. The possibility of medical consumables and diabetes delivery products being included -
Market size estimation for Radiography equipment in India
- March 22, 2018
- Posted by: Team EMeRG
- Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Competitive Intelligence, Diagnostic Imaging, GTM Strategy, Pricing Research, Value Prop Assessment
Overview: Radiography Equipment Market in India Valued at $45Mn in 2016, the Indian Radiography market is being driven by strong preference for Digital Radiography (DR) by large corporate and government hospitals due to increasing patient footfall. The predecessor of DR, the Analog X-ray segment is likely to exhibit muted growth due to the increasing preference -
Pricing and Value Proposition Assessment for Ultrasound Machines In India
- November 15, 2017
- Posted by: Team EMeRG
- Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Diagnostic Imaging, Market Entry Assessment, Maternal & Infant Care, NPI Research, Pricing Research, Value Prop Assessment
“45% of the non-owners of ultrasound interviewed were Obs/Gyn specialists, practicing for >16 years. Clearly, adoption of ultrasound in India would take more than just lowering price points…” Overview: Ultrasound Market in India Valued at $170Mn in 2016, the market for diagnostic ultrasound in India is characterized by immense fragmentation. While on the one hand, -
Evaluation of business models and marketing strategies for a Tele-Health solution
- February 13, 2017
- Posted by: Team EMeRG
- Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Competitive Intelligence, GTM Strategy, Healthcare IT, Market Entry Assessment, NPI Research, Pricing Research, Value Prop Assessment
Overview: Market for Tele-Health solutions in India Limited healthcare access across rural and semi-urban India is causing significant loss w.r.t. disability adjusting life years amounting to economic loses worth $200 trillion. Despite 70% of the population being spread across rural India, urban parts account for 60% of the workforce. Tele-health initiatives, though not highly commercially viable -
New Product Introduction: Non-invasive solution for measuring HbA1c
- October 10, 2016
- Posted by: Team EMeRG
- Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Competitive Intelligence, Diabetes Management, Ethnographic Research, Market Entry Assessment, NPI Research, Pricing Research, SUBCONTINENT
Overview: Market for HbA1c Tests The global market for Self monitoring blood glucose (SMBG) devices was valued at $11Bn in 2015 and is characterized by intense competition and low entry barriers for low-cost manufacturers. In India, the market for SMBG devices and strips was valued at about $98Mn in 2015.While the annual median expenditure on -
New Product Introduction: Low-cost visualization device for body orifices
- September 10, 2016
- Posted by: Team EMeRG
- Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Competitive Intelligence, Ethnographic Research, Market Entry Assessment, NPI Research, Operating Room devices, Pricing Research
Overview: Market for Endoscopic Products in India The global market for endoscopic products was valued at over $29Bn in 2015, growing at over 6% annually. India represents about 0.35% of the global markets, being valued at $115Mn. Rigid endoscopes continue to dominate sales in India, accounting for over 62% of the market revenues. Future innovations -
Addressable market estimates for OR and Critical Care devices across ASEAN and APAC
- May 21, 2016
- Posted by: Tanuja Khanolkar
- Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, ICU equipment, Market Entry Assessment, Maternal & Infant Care, Operating Room devices, Patient Monitoring
Our Client: A global leader in diagnostic imaging equipment and related software and Healthcare IT solutions Challenge Statement: The client wished to map the entire hospital infrastructure in ASEAN and APAC to assess the addressable market for its large product and solutions portfolio to ensure improved sales efficiency in the region EMeRG Approach: Indepth secondary research was conducted to understand the current infrastructure in ASEAN and APAC. EMeRG began with creating a detailed list of all hospitals across 14 countries and understanding their overall demographics including bedsize. Once the hospitals were broadly segmented based on bedsize, ownership type and regions, EMeRG estimated the critical attributes including no. of ICU beds, NICU beds and ORs in each. This was followed by creating a deeper bifurcation based on level of care and procedural mix. ICU beds and NICU beds were divided into Level I/II/III across certain countries; while ORs were classified into Major and Minor ORs. Topdown methodology for TAM estimation was adequately validated through bottomup methodology including detailed listing of infrastructure and installed base (IB) Research Outcome: The research helped the clients streamline their current understanding of total addressable market. A heat map was proposed to understand current regions within a country with high IB (and hence high replacement rates) vs. client's current fieldreach or feetonstreet. The insights are now being internalized to improve sales force effectiveness strategies within direct sales and indirect channel partners EMeRG Value Add: Healthcare expertise - EMeRG's indepth understanding of the hospital infrastructure in ASEAN helped us leverage local resources to map and size the hospital demographics Need local insights for -
New Product Introduction and Market Feasibility Assessment: Tele-Monitoring Solution for Critical Care
- January 9, 2016
- Posted by: Team EMeRG
- Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, GTM Strategy, Healthcare IT, ICU equipment, Market Entry Assessment, NPI Research, Patient Monitoring, Value Prop Assessment
Overview: Global Tele-ICU Market Valued at over $1.5Bn, the global market for tele-ICU is growing at double digits. With acute shortage of intensivists across most countries globally, the need for a command center that continuously monitors patients in critical care units is on the rise. The need-gaps are potentially more searing in emerging markets where a -
Feasibility assessment and pricing strategy for the launch of diagnostic lab chains in India
- December 13, 2015
- Posted by: Team EMeRG
- Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Diagnostic Imaging, GTM Strategy, Market Entry Assessment, NPI Research, Pricing Research, Value Prop Assessment
Overview: Market for Diagnostic labs in India In India, 70% of the treatment decisions are made based on lab results. Valued at over $7Bn, the diagnostics industry in India is largely unregulated and unorganized. While accreditation is optional, there are <800 medical labs that have been accredited by NABL. This represents roughly 1% of all
- 1
- 2
RECOMMENDED ARTICLES
Contact us at EMeRG for your med-tech business intelligence needs in emerging markets